Where Can Patients Obtain Information on the Preapproval Access Pathway to Investigational Treatment in Japan? A Survey of Patient Advocacy Organizations’ Websites-Reference-Cited by-同舟云学术

Where Can Patients Obtain Information on the Preapproval Access Pathway to Investigational Treatment in Japan? A Survey of Patient Advocacy Organizations’ Websites

Published:2019-10-08 Issue:8 Volume:8 Page:978-983
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Nakada Haruka¹,Takashima Kyoko²

Affiliation:

1. Division of Bioethics and Healthcare LawCenter for Public Health SciencesNational Cancer Center Chuo‐ku Tokyo Japan

2. Medical Genomics CenterNational Center for Global Health and Medicine Shinjuku‐ku Tokyo Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.745

Reference17 articles.

1. Access to clinical trials among oncology patients: results of a cross sectional survey

2. Adolescent angst: enrollment on clinical trials

3. Ten-Year Experience for the Center for Drug Evaluation and Research, Part 2: FDA’s Role in Ensuring Patient Safety

4. S.204‐Trickett Wendler Frank Mongiello Jordan McLinn and Matthew Bellina Right to Try Act of 2017 115th Congress (2017‐2018) January 2017.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ClinicalTrials.gov as a Source of Information About Expanded Access Programs: Cohort Study;Journal of Medical Internet Research;2021-10-28

2. Public availability of results of ClinicalTrials.gov‐registered expanded access studies;British Journal of Clinical Pharmacology;2021-05-22

3. ClinicalTrials.gov as a Source of Information About Expanded Access Programs: Cohort Study (Preprint);2021-01-02

4. Ethics framework for treatment use of investigational drugs;BMC Medical Ethics;2020-11-18

5. Comparative Assessment of Non-trial Access to Investigational Medical Products in the U.S. and Japan;Therapeutic Innovation & Regulatory Science;2020-10-23